Supporting promising cancer treatments in partnership with The University of Texas MD Anderson Cancer Center

The Cancer Focus Fund is an oncology-focused investment fund which invests in compelling cancer therapies at or near the FDA Phase 1 or Phase 2 human clinical trial regimen. The fund offers business, management, IP, clinical, scientific and regulatory support through experienced and proven professionals.

At the Cancer Focus Fund, we invest in promising therapies in late preclinical development through Phase I and Phase Ib/II clinical trials. Our objective is to provide support to accelerate the development of these therapeutics together with the clinical trials expertise and infrastructure of MD Anderson.

Through our unique approach, we believe the Cancer Focus Fund has the potential to bring more treatments to patients in need while also rewarding our investors.